DOI 10.1080/17474086.2026.2636163
The role of gene polymorphisms in the susceptibility and therapeutic response of chronic immune thrombocytopenic purpura.
Аннотация
INTRODUCTION
Chronic immune thrombocytopenic purpura (cITP) is a prolonged autoimmune disorder characterized by persistent low platelet counts and the presence of anti-platelet antibodies. The disease exhibits heterogeneity in severity and therapeutic response, which complicates management and underscores the importance of identifying predictive biomarkers.
AREAS COVERED: This review examines gene polymorphisms in cytokines, immune receptors, and transcription factors associated with susceptibility to cITP. Additionally, this study highlights the impact of specific genetic polymorphisms in the IL6, IL10, CXCL12, FCGR, TLR4, ICOS, DNAM1, and ABCB1 genes on the response to treatment in patients with cITP. A comprehensive search of PubMed, Scopus, and Web of Science from 1998 to July 2025 was performed to include all relevant studies.
EXPERT OPINION: Genetic profiling has the potential to refine our understanding of cITP and guide clinical decision-making. Advances in this field may enable the development of personalized medicine approaches, where genetic information is integrated into diagnostic and therapeutic strategies to optimize patient outcomes.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.